FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:993-997 April 13, 1995 Number 15 Next

	Full Text PDF Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur in patients with antiphospholipid antibodies. The optimal treatment of these patients is unclear. We assessed the efficacy of warfarin, low-dose aspirin, or both in the secondary prevention of thrombosis in patients with the syndrome.

Methods One hundred forty-seven patients (124 [84 percent] of whom were female) with the antiphospholipid-antibody syndrome and a history of thrombosis were studied retrospectively. The syndrome was primary in 62 patients and was associated with systemic lupus erythematosus in 66 patients and lupus-like disease in 19. Each patient's history was reviewed.

Results One hundred one patients (69 percent) had a total of 186 recurrences of thrombosis. The median time between the initial thrombosis and the first recurrence was 12 months (range, 0.5 to 144 months). Treatment with high-intensity warfarin (producing an international normalized ratio of >3) with or without low-dose aspirin (75 mg per day) was significantly more effective (P<0.001 by the log-rank test) than treatment with low-intensity warfarin (producing an international normalized ratio of <3) with or without low-dose aspirin or treatment with aspirin alone in preventing further thrombotic events (recurrence rates per patient-year, 0.013, 0.23, and 0.18, respectively). The rate of recurrence of thrombosis was highest (1.30 per patient-year) during the first six months after the cessation of warfarin therapy. Complications involving bleeding occurred in 29 patients during warfarin therapy and were severe in 7 (0.071 and 0.017 occurrence per patient-year, respectively).

Conclusions The risk of recurrent thrombosis in patients with the antiphospholipid-antibody syndrome is high. Long-term anticoagulation therapy in which the international normalized ratio is maintained at or above 3 is advisable in these patients.

Source Information

From the Lupus and Arthritis Research Unit, Rayne Institute (M.A.K., M.J.C., F.M., G.R.V.H.); the Department of Public Health Medicine, United Medical and Dental Schools of Guy's and St. Thomas's Hospitals (N.A.T.); and the Hemophilia Center, St. Thomas's Hospital (B.J.H.) — all in London.

Address reprint requests to Dr. Khamashta at the Lupus Research Unit, Rayne Institute, St. Thomas's Hospital, London SE1 7EH, United Kingdom.

Full Text of this Article

Related Letters:

Thrombosis in the Antiphospholipid-Antibody Syndrome
Violi F., Ferro D., Valesini G., Rapaport S. I., Le D. T., Slivka A., Walz E., Cole A. J., Nasr S. Z., Parke A. L., Khamashta M. A., Taub N. A., Hunt B. J., Lockshin M. D.
Extract | Full Text  
N Engl J Med 1995; 333:665-667, Sep 7, 1995. Correspondence

Anticoagulation for Venous Thromboembolism
Bucciarelli P., Alatri A., Moia M., Khamashta M. A., Williams F. M.K., Hunt B. J., Kearon C., Ginsberg J. S., Gent M.
Extract | Full Text  
N Engl J Med 1999; 341:539-540, Aug 12, 1999. Correspondence

This article has been cited by other articles:

• Greco, T. P., Conti-Kelly, A. M., Greco, T. Jr, Doyle, R., Matsuura, E., Anthony, J. R., Lopez, L. R. (2009). Newer Antiphospholipid Antibodies Predict Adverse Outcomes in Patients With Acute Coronary Syndrome. Am J Clin Pathol 132: 613-620 [Abstract] [Full Text]  
• Giannakopoulos, B., Krilis, S. A. (2009). How I treat the antiphospholipid syndrome. Blood 114: 2020-2030 [Abstract] [Full Text]  
• Cervera, R, Boffa, M-C, Khamashta, M., Hughes, G. (2009). The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus 18: 889-893 [Abstract]  
• Cervera, R, Khamashta, M A, Shoenfeld, Y, Camps, M T, Jacobsen, S, Kiss, E, Zeher, M M, Tincani, A, Kontopoulou-Griva, I, Galeazzi, M, Bellisai, F, Meroni, P L, Derksen, R H W M, de Groot, P G, Gromnica-Ihle, E, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quere, I, Hachulla, E, Vasconcelos, C, Roch, B, Fernandez-Nebro, A, Piette, J-C, Espinosa, G, Bucciarelli, S, Pisoni, C N, Bertolaccini, M L, Boffa, M-C, Hughes, G R V, on behalf of the Euro-Phospholipid Project Group (, (2009). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 68: 1428-1432 [Abstract] [Full Text]  
• Tan, B., Thong, B., Shivananda, S, Han, W., Chng, H. (2009). Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort. Lupus 18: 752-758 [Abstract]  
• Cianci, R., Gigante, A., Barbano, B., Zaccaria, A., Polidori, L., Borghesi, F., Gasperini, L., Di Donato, D., Amoroso, A. (2009). Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome. BMJ Case Reports 2009: bcr1220081342-bcr1220081342 [Abstract] [Full Text]  
• Zhu, T., Martinez, I., Emmerich, J. (2009). Venous Thromboembolism: Risk Factors for Recurrence. Arterioscler. Thromb. Vasc. Bio. 29: 298-310 [Abstract] [Full Text]  
• Farmer-Boatwright, M. K., Roubey, R. A.S. (2009). Venous Thrombosis in the Antiphospholipid Syndrome. Arterioscler. Thromb. Vasc. Bio. 29: 321-325 [Abstract] [Full Text]  
• Matsuura, E, Lopez, L. (2008). Autoimmune-mediated atherothrombosis. Lupus 17: 879-888 [Abstract]  
• Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G. (2008). Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 160S-198S [Abstract] [Full Text]  
• Horner, K. E., Phillips, B. B., Newkirk, E., McDanel, D. L., Kaboli, P. (2008). Evaluation of anticoagulation in patients with antiphospholipid syndrome. Am J Health Syst Pharm 65: 964-967 [Abstract] [Full Text]  
• Lockshin, M., Derksen, R. (2008). New developments in lupus-associated antiphospholipid syndrome. Lupus 17: 443-446 [Abstract]  
• Davie, C A, O'Brien, P (2008). Stroke and pregnancy. J. Neurol. Neurosurg. Psychiatry 79: 240-245 [Abstract] [Full Text]  
• Gorki, H., Malinovski, V., Stanbridge, R. D.L. (2008). The antiphospholipid syndrome and heart valve surgery. Eur. J. Cardiothorac. Surg. 33: 168-181 [Abstract] [Full Text]  
• Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Gordon, C, Boumpas, D T (2008). EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67: 195-205 [Abstract] [Full Text]  
• Swigris, J. J., Fischer, A., Gilles, J., Meehan, R. T., Brown, K. K. (2008). Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus. Chest 133: 271-280 [Abstract] [Full Text]  
• Goldenberg, N. A. (2008). Thrombophilia States and Markers of Coagulation Activation in the Prediction of Pediatric Venous Thromboembolic Outcomes: A Comparative Analysis with Respect to Adult Evidence. ASH Education Book 2008: 236-244 [Abstract] [Full Text]  
• Bounameaux, H., Perrier, A. (2008). Duration of Anticoagulation Therapy for Venous Thromboembolism. ASH Education Book 2008: 252-258 [Abstract] [Full Text]  
• Avcin, T., Silverman, E. (2007). Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus 16: 627-633 [Abstract]  
• Garcia-Carrasco, M., Galarza, C., Gomez-Ponce, M., Cervera, R., Rojas-Rodriguez, J., Espinosa, G., Bucciarelli, S., Gomez-Puerta, J.A., Bove, A., Escarcega, R.O., Font, J. (2007). Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus 16: 366-373 [Abstract]  
• Krause, I, Leibovici, L, Blank, M, Shoenfeld, Y (2007). Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus 16: 176-180 [Abstract]  
• Rand, J. H. (2007). The Antiphospholipid Syndrome. ASH Education Book 2007: 136-142 [Abstract] [Full Text]  
• Szekanecz, Z, Shoenfeld, Y (2006). Lupus and cardiovascular disease: the facts. Lupus 15: 3-10 [Abstract]  
• Scarvelis, D., Wells, P. S. (2006). Diagnosis and treatment of deep-vein thrombosis.. CMAJ 175: 1087-1092 [Abstract] [Full Text]  
• Tincani, A., Rebaioli, C. B., Taglietti, M., Shoenfeld, Y. (2006). Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45: iv8-iv13 [Abstract] [Full Text]  
• Giles, I., Lambrianides, N., Pattni, N., Faulkes, D., Latchman, D., Chen, P., Pierangeli, S., Isenberg, D., Rahman, A. (2006). Arginine Residues Are Important in Determining the Binding of Human Monoclonal Antiphospholipid Antibodies to Clinically Relevant Antigens. J. Immunol. 177: 1729-1736 [Abstract] [Full Text]  
• Wahl, D., Regnault, V. (2006). Treatment of antiphospholipid antibody syndrome.. JAMA 296: 42-43 [Full Text]  
• Ben-Ami, D, Bar-Meir, E, Shoenfeld, Y (2006). Stenosis in Antiphospholipid Syndrome: A New Finding with Clinical Implications. Lupus 15: 466-472 [Abstract]  
• Ostertag, M V., Liu, X, Henderson, V, Pierangeli, S S (2006). A peptide that mimics the Vth region of {beta}2glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Lupus 15: 358-365 [Abstract]  
• Ingegnoli, F, Soldi, A, Meani, L, Zeni, S, Fantini, F (2006). Primary antiphospholipid syndrome associated with small aorta syndrome: a case report. Lupus 15: 236-239 [Abstract]  
• Paran, D, Chapman, J, Korczyn, A D, Elkayam, O, Hilkevich, O, Groozman, G B, Levartovsky, D, Litinsky, I, Caspi, D, Segev, Y, Drory, V E (2006). Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis. Ann Rheum Dis 65: 525-528 [Abstract] [Full Text]  
• Lopez-Pedrera, C., Buendia, P, Aguirre, M A, Velasco, F, Cuadrado, M J (2006). Antiphospholipid syndrome and tissue factor: a thrombotic couple. Lupus 15: 161-166 [Abstract]  
• Bertolaccini, M L, Khamashta, M A (2006). Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15: 172-178 [Abstract]  
• Lim, W., Crowther, M. A., Eikelboom, J. W. (2006). Management of Antiphospholipid Antibody Syndrome: A Systematic Review. JAMA 295: 1050-1057 [Abstract] [Full Text]  
• Castro, I, Rios, J J, Iniesta, N, Perez, I, Robles, A, Gil, A (2005). Letter to the Editor. Lupus 14: 979-980  
• Koutoulidis, V, Chatziioannou, A, Kostopoulos, C, Kontogiannis, S, Skiadas, V, Mourikis, D, Vlahos, L (2005). Primary antiphospholipid syndrome: a unique presentation with multiple visceral aneurysms. Ann Rheum Dis 64: 1793-1794 [Full Text]  
• Navarrete, N, Macias, P, Jaen, F, Hidalgo, C, Caliz, R, Jimenez-Alonso, J (2005). Two cases of catastrophic antiphospholipid syndrome. Lupus 14: 907-909 [Abstract]  
• Bertolaccini, M L, Gomez, S, Pareja, J F P, Theodoridou, A, Sanna, G, Hughes, G R V, Khamashta, M A (2005). Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis 64: 1639-1643 [Abstract] [Full Text]  
• Statkute, L., Traynor, A., Oyama, Y., Yaung, K., Verda, L., Krosnjar, N., Burt, R. K. (2005). Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood 106: 2700-2709 [Abstract] [Full Text]  
• Matsuura, E, Kobayashi, K, Inoue, K, Lopez, L R, Shoenfeld, Y (2005). Oxidized LDL/{beta}2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14: 736-741 [Abstract]  
• Ruiz-Irastorza, G., Khamashta, M. A. (2005). Stroke and antiphospholipid syndrome: the treatment debate. Rheumatology (Oxford) 44: 971-974 [Abstract] [Full Text]  
• Abdullah, B J J, Mohammad, N, Sangkar, J V, Abd Aziz, Y F, Gan, G G, Goh, K Y, Benedict, I (2005). Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). Br. J. Radiol. 78: 596-600 [Abstract] [Full Text]  
• Turiel, M., Sarzi-Puttini, P., Peretti, R., Rossi, E., Atzeni, F., Parsons, W., Doria, A. (2005). Thrombotic Risk Factors In Primary Antiphospholipid Syndrome: A 5-Year Prospective Study. Stroke 36: 1490-1494 [Abstract] [Full Text]  
• Letang, E, Rodriguez-Carballeira, M, Muchart, J, Torres, J, de Echaguen, A O., Garau, J (2005). Letter to the Editor. Lupus 14: 336-337  
• Ferreira, S., D'Cruz, D. P., Hughes, G. R. V. (2005). Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?. Rheumatology (Oxford) 44: 434-442 [Abstract] [Full Text]  
• Stammers, A. H, Dorion, R P., Trowbridge, C., Yen, B., Klayman, M., Murdock, J. D, Woods, E., Gilbert, C. (2005). Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report. Perfusion 20: 115-120 [Abstract]  
• Nojima, J., Kuratsune, H., Suehisa, E., Iwatani, Y., Kanakura, Y. (2005). Acquired Activated Protein C Resistance Associated with IgG Antibodies against {beta}2-Glycoprotein I and Prothrombin as a Strong Risk Factor for Venous Thromboembolism. Clin. Chem. 51: 545-552 [Abstract] [Full Text]  
• Sangle, S. R., D'Cruz, D. P., Abbs, I. C., Khamashta, M. A., Hughes, G. R. V. (2005). Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) 44: 372-377 [Abstract] [Full Text]  
• Ortel, T. L. (2005). Thrombosis and the Antiphospholipid Syndrome. ASH Education Book 2005: 462-468 [Abstract] [Full Text]  
• Wittkowsky, A. K. (2004). Anticoagulation in Hypercoagulable Conditions: Special Considerations in the Treatment and Prevention of Venous Thromboembolism. Journal of Pharmacy Practice 17: 308-316 [Abstract]  
• Parke, A (2004). Short and long-term maternal outcomes in patients with phospholipid antibodies. Lupus 13: 703-704 [Abstract]  
• Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., Hylek, E. (2004). The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 204S-233S [Abstract] [Full Text]  
• Buller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., Raskob, G. E. (2004). Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 401S-428S [Abstract] [Full Text]  
• Greaves, M. (2004). Masterclass series in peripheral arterial disease: Acquired thrombophilia. Vasc Med 9: 215-218  
• Boura, P., Tselios, K., Skendros, P., Kountouras, J. (2004). Antiphospholipid Syndrome in Greece: Clinical and Immunological Study and Review of the Literature. ANGIOLOGY 55: 421-430 [Abstract]  
• Kyrle, P. A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., Eichinger, S. (2004). The Risk of Recurrent Venous Thromboembolism in Men and Women. NEJM 350: 2558-2563 [Abstract] [Full Text]  
• Yaqub, S., Moder, K. G., Lacy, M. Q. (2004). Severe, Reversible Pulmonary Hypertension in a Patient With Monoclonal Gammopathy and Features of Dermatomyositis. Mayo Clin Proc. 79: 687-689 [Abstract]  
• Ozturk, M. A., Haznedaroglu, I. C., Turgut, M., Goker, H. (2004). Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia. CLIN APPL THROMB HEMOST 10: 89-126 [Abstract]  
• O'Rourke, F., Dean, N., Akhtar, N., Shuaib, A. (2004). Current and future concepts in stroke prevention. CMAJ 170: 1123-1133 [Abstract] [Full Text]  
• Caprini, J. A., Glase, C. J., Anderson, C. B., Hathaway, K. (2004). Laboratory Markers in the Diagnosis of Venous Thromboembolism. Circulation 109: I-4-I-8 [Abstract] [Full Text]  
• Spencer, H L, Kamisawa, T, Funata, N, Okamoto, A (2004). Primary antiphospholipid syndrome as a new cause of autoimmune pancreatitis * Author's reply. Gut 53: 468-468 [Full Text]  
• APASS Investigators, (2004). Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke. JAMA 291: 576-584 [Abstract] [Full Text]  
• Yagi, K, Kawano, M, Haraki, T, Higashikata, T, Ueda, K, Okada, T, Koni, I, Mabuchi, H (2004). Long-term efficacy of immunoadsorbent plasmapheresis in a patient with Budd-Chiari syndrome due to antiphospholipid syndrome: case report with nine-year follow-up. Lupus 13: 135-138 [Abstract]  
• Ruiz-Irastorza, G., Egurbide, M.-V., Ugalde, J., Aguirre, C. (2004). High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus. Arch Intern Med 164: 77-82 [Abstract] [Full Text]  
• Wajed, J., Ahmad, Y., Durrington, P. N., Bruce, I. N. (2004). Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management. Rheumatology (Oxford) 43: 7-12 [Full Text]  
• Katzav, A, Chapman, J, Shoenfeld, Y (2003). CNS dysfunction in the antiphospholipid syndrome. Lupus 12: 903-907 [Abstract]  
• Connor, P, Hunt, B J (2003). Cerebral haemostasis and antiphospholipid antibodies. Lupus 12: 929-934 [Abstract]  
• Sanna, G, Bertolaccini, M L, Mathieu, A (2003). Central nervous system lupus: a clinical approach to therapy. Lupus 12: 935-942 [Abstract]  
• Campos, L M., Kiss, M H, D'Amico, E A, Silva, C A A. (2003). Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 12: 820-826 [Abstract]  
• Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M., Kovacs, M. J. (2003). A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. NEJM 349: 1133-1138 [Abstract] [Full Text]  
• Lockshin, M. D., Erkan, D. (2003). Treatment of the Antiphospholipid Syndrome. NEJM 349: 1177-1179 [Full Text]  
• Tektonidou, M. G, Vlachoyiannopoulos, P. G (2003). Letter to the Editor. Lupus 12: 723-724  
• Schulman, S. (2003). Care of Patients Receiving Long-Term Anticoagulant Therapy. NEJM 349: 675-683 [Full Text]  
• Derksen, R.H.W.M., de Groot, P.G., Kappelle, L.J. (2003). Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome. Neurology 61: 111-114 [Abstract] [Full Text]  
• Shoenfeld, Y (2003). Systemic antiphospholipid syndrome. Lupus 12: 497-498 [Abstract]  
• Alarcon-Segovia, D, Boffa, M C, Branch, W, Cervera, R, Gharavi, A, Khamashta, M, Shoenfeld, Y, Wilson, W, Roubey, R (2003). Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 12: 499-503 [Abstract]  
• Meroni, P L, Moia, M, Derksen, R H., Tincani, A, McIntyre, J A, Arnout, J M., Koike, T, Piette, J-C, Khamashta, M A, Shoenfeld, Y (2003). Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis. Lupus 12: 504-507 [Abstract]  
• Brey, R L, Chapman, J, Levine, S R, Ruiz-Irastorza, G, Derksen, R H., Khamashta, M, Shoenfeld, Y (2003). Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus 12: 508-513 [Abstract]  
• Hanly, J. G. (2003). Antiphospholipid syndrome: an overview. CMAJ 168: 1675-1682 [Abstract] [Full Text]  
• Hyers, T. M. (2003). Duration of Anticoagulation in Venous Thromboembolism. Arch Intern Med 163: 1265-1266 [Full Text]  
• van Dongen, C. J. J., Vink, R., Hutten, B. A., Buller, H. R., Prins, M. H. (2003). The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis. Arch Intern Med 163: 1285-1293 [Abstract] [Full Text]  
• Erkan, D, Asherson, R A, Espinosa, G, Cervera, R, Font, J, Piette, J-C, Lockshin, M D (2003). Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 62: 530-533 [Abstract] [Full Text]  
• Ramos-Casals, M, Garcia-Carrasco, M, Brito, M P, Lopez-Soto, A, Font, J (2003). Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus 12: 341-355 [Abstract]  
• Streiff, M. B. (2003). Vena Caval Filters: A Review for Intensive Care Specialists. J Intensive Care Med 18: 59-79 [Abstract]  
• Galli, M., Luciani, D., Bertolini, G., Barbui, T. (2003). Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101: 1827-1832 [Abstract] [Full Text]  
• Deitcher, S. R, Gomes, M. P. (2003). Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med 8: 33-46 [Abstract]  
• Sanna, G., Bertolaccini, M. L., Cuadrado, M. J., Khamashta, M. A., Hughes, G. R. V. (2003). Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) 42: 200-213 [Abstract] [Full Text]  
• Hughes, G R V (2003). Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad. Med. J. 79: 81-83 [Abstract] [Full Text]  
• Sanni, G., Khamashta, M. A (2003). Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus. Lupus 12: 1-2  
• Warkentin, T. E., Aird, W. C., Rand, J. H. (2003). Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome. ASH Education Book 2003: 497-519 [Abstract] [Full Text]  
• Prandoni, P., Lensing, A. W.A., Prins, M. H., Bernardi, E., Marchiori, A., Bagatella, P., Frulla, M., Mosena, L., Tormene, D., Piccioli, A., Simioni, P., Girolami, A. (2002). Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism. ANN INTERN MED 137: 955-960 [Abstract] [Full Text]  
• Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., Girolami, A. (2002). Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484-3488 [Abstract] [Full Text]  
• Maslowski, L., McBane, R., Alexewicz, P., Wysokinski, W. E (2002). Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med 7: 259-264 [Abstract]  
• Bick, R. L., Alfar, H., Goedecke, C. (2002). Thrombophilic Causes of Retinal Vascular Thrombosis: Etiology and Treatment Outcomes. CLIN APPL THROMB HEMOST 8: 315-318  
• Joffe, H. V., Goldhaber, S. Z. (2002). Upper-Extremity Deep Vein Thrombosis. Circulation 106: 1874-1880 [Full Text]  
• Bloom, B. J., Smith, R. N. (2002). Case 29-2002 - A 17-Year-Old Boy with Acute Mitral Regurgitation and Pulmonary Edema. NEJM 347: 921-928 [Full Text]  
• Goichot, B., Perrin, A.-E., Thomas, R. H. (2002). Hypercoagulable Disorders. Arch Intern Med 162: 1785-1787 [Full Text]  
• Moll, S., Ortel, T. L. (2002). Antiphospholipid Antibodies. Arch Intern Med 162: 1783-1784 [Full Text]  
• Alfayate, J. M., Acin, F., Bueno, A., March, J. R., Lopez-Quintana, A., Cancer, S., Ros, R. (2002). Aortoiliac Thrombosis in Antiphospholipid Syndrome: Case Report and Literature Review. VASC ENDOVASCULAR SURG 36: 311-315 [Abstract]